These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34063186)

  • 1. Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review.
    de Almeida NAA; Ribeiro CRA; Raposo JV; de Paula VS
    Viruses; 2021 May; 13(5):. PubMed ID: 34063186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
    J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Hepatitis viruses, human T-cell leukemia viruses, herpesviruses, and Epstein-Barr virus.
    Mui UN; Haley CT; Vangipuram R; Tyring SK
    J Am Acad Dermatol; 2019 Jul; 81(1):23-41. PubMed ID: 30502415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral Vectors for Cancer Gene Therapy.
    Schambach A; Morgan M
    Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Papillomaviruses and Merkel cell polyomavirus.
    Haley CT; Mui UN; Vangipuram R; Rady PL; Tyring SK
    J Am Acad Dermatol; 2019 Jul; 81(1):1-21. PubMed ID: 30502418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers.
    Seyed-Khorrami SM; Soleimanjahi H; Łos MJ; Zandi K; Emameh RZ
    Eur J Pharmacol; 2023 Jan; 939():175393. PubMed ID: 36435236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
    Dzobo K
    OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted genome editing tools for disease modeling and gene therapy.
    Cai M; Yang Y
    Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genome-editing: focus on the off-target effects].
    He X; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
    Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
    Front Immunol; 2018; 9():1711. PubMed ID: 30233563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
    Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
    J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.
    Ohno M; Otsuka M; Kishikawa T; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jun; 21(23):7084-8. PubMed ID: 26109795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic gene editing: delivery and regulatory perspectives.
    Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
    Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.